1. Bavencio (avelumab) . Prescribing information. EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, 2022.
2. Bavencio (avelumab) . Summary of product characteristics. Merck Europe B.V., Amsterdam, Netherlands an affiliate of Merck KGaA, 2022.
3. Japanese Urological Association . Supplemental to Clinical Practice Guidelines for Bladder Cancer. 2019. Available: https://www.urol.or.jp/lib/files/other/guideline/39_bladder_cancer_2019_rev2021_info.pdf [Accessed 12 Jan 2023].
4. Bavencio (avelumab) . Prescribing information. Merck Serono Ltd., Herzliya, Israel: an affiliate of Merck KGaA, 2021.
5. Bavencio (avelumab) . Product monograph, Canada. EMD Serono, Inc., Mississauga, Ontario, Canada: an affiliate of Merck KGaA, 2022.